» Articles » PMID: 32778100

Study of Hospitalization and Mortality in Korean Diabetic Patients Using the Diabetes Complications Severity Index

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2020 Aug 12
PMID 32778100
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The prevalence of type 2 diabetes mellitus (T2DM) is expected to increase from 7.7% in 2017 to 8.4% in 2045 worldwide. Diabetes complications contribute to morbidity and mortality. To evaluate whether the diabetes complications severity index (DCSI) was associated with increased risks of mortality and hospitalization.

Methods: A retrospective cohort study was conducted using the National Health Insurance Database (NHID) sample cohort of 1,102,047 patients (2002-2015) in Korea. Diabetes complications were evaluated at 2 years after the initial diagnosis and during the subsequent follow-up period (mean duration 6.56 ± 2.81 years). The type and severity of complications were evaluated on the basis of the International Classification of Disease Ninth (ICD-9) codes used in DCSI with 7 categories and 55 subcategories of complications. The Cox proportional hazard and Poisson regression models were used to evaluate the mortality and hospitalization rates. The incidence and relative risk of diabetes complications as well as the risk of mortality and hospitalization were the main outcome measures.

Results: A total of 27,871 patients were finally included and grouped by the number of complications present at 2 years. Four hundred ninety patients (5.37%) died without complications, 659 (7.31%) died with one complication and 1153 (11.85%) died with two or more complications. As DCSI at index date increased, the risk of additional new diabetes complications increased by 26% [relative risk (RR) 1.26, 95% CI 1.25-1.27]. The risks of mortality and hospitalization were linearly related to DCSI [hazard ratio 1.13 (95% CI 1.11-1.16), relative risk 1.04 (95% CI 1.03-1.06)].

Conclusions: Patients with higher incidence and severity of diabetes complications have increased risks of mortality and hospitalization.

Citing Articles

Is avoidable diabetes-related hospitalization in older patients with type 2 diabetes mellitus associated with increased health expenditure?: A nationwide retrospective cohort study in South Korea.

Lee W, Lee G, Son N, Han K, Chun S, Son Y Prev Med Rep. 2025; 49():102946.

PMID: 39807182 PMC: 11729008. DOI: 10.1016/j.pmedr.2024.102946.


Predictive models and determinants of mortality among T2DM patients in a tertiary hospital in Ghana, how do machine learning techniques perform?.

Kpene G, Lokpo S, Darfour-Oduro S BMC Endocr Disord. 2025; 25(1):9.

PMID: 39794757 PMC: 11720850. DOI: 10.1186/s12902-025-01831-5.


Availability and affordability of diabetes healthcare services associated with the frequency of diabetes-related complications.

Alijanzadeh M, Hashemipour S, Attaran F, Saremi S, Modarresnia L, Ghafelehbashi H BMC Health Serv Res. 2024; 24(1):1586.

PMID: 39695678 PMC: 11654362. DOI: 10.1186/s12913-024-12065-x.


Relationships of Multidimensional Factors to Diabetes Complications: A Cross-Sectional, Correlational Study.

Heo S, Kang J, Barbe T, Kim J, Bertulfo T, Troyan P West J Nurs Res. 2024; 46(9):664-673.

PMID: 39171415 PMC: 11380359. DOI: 10.1177/01939459241271332.


Effect of motivated physicians and elderly patients with hypertension or type 2 diabetes mellitus in prepared communities on health behaviours and outcomes: A population-based PS matched retrospective cohort study during five-year follow-up period.

Park E, Kim H, Lim Y, Lee S, Lee W PLoS One. 2024; 19(2):e0296834.

PMID: 38349922 PMC: 10863870. DOI: 10.1371/journal.pone.0296834.


References
1.
Fiorentino T, Succurro E, Andreozzi F, Sciacqua A, Perticone F, Sesti G . One-hour post-load hyperglycemia combined with HbA1c identifies individuals with higher risk of cardiovascular diseases: Cross-sectional data from the CATAMERI study. Diabetes Metab Res Rev. 2018; 35(2):e3096. DOI: 10.1002/dmrr.3096. View

2.
Lee J, Lee J, Park S, Shin S, Kim K . Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2016; 46(2):e15. DOI: 10.1093/ije/dyv319. View

3.
Wanner C, Inzucchi S, Lachin J, Fitchett D, von Eynatten M, Mattheus M . Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes. N Engl J Med. 2016; 375(4):323-34. DOI: 10.1056/NEJMoa1515920. View

4.
Yoo H, Park I, Kim D, Lee S . Effects of sarpogrelate on microvascular complications with type 2 diabetes. Int J Clin Pharm. 2019; 41(2):563-573. DOI: 10.1007/s11096-019-00794-7. View

5.
Hex N, Bartlett C, Wright D, Taylor M, Varley D . Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012; 29(7):855-62. DOI: 10.1111/j.1464-5491.2012.03698.x. View